$17.30
0[0.00%]
At close: Apr 22
$17.30
0[0.00%]
PreMarket: 7:40PM EDT
Avadel Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Avadel Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | AM | AVDL | Q1 | -$0.48 | -$0.21 | — | — | $0.00 | $26.67M | — | — | Get Alert |
03/04/2024 | AM | AVDL | Q4 | -$0.44 | -$0.29 | -$0.32 | -10.34% | $0.00 | $18.11M | $19.45M | 7.42% | Get Alert |
11/08/2023 | AM | AVDL | Q3 | -$0.33 | -$0.37 | -$0.41 | -10.81% | $0.00 | $5.09M | $7.01M | 37.80% | Get Alert |
08/09/2023 | AM | AVDL | Q2 | -$1.01 | -$0.38 | -$0.66 | -73.68% | $0.00 | $630.00K | $1.50M | 137.46% | Get Alert |
05/04/2023 | AM | AVDL | Q1 | -$0.45 | -$0.38 | -$0.48 | -26.32% | $0.00 | — | $0.00 | — | Get Alert |
03/30/2023 | AM | AVDL | Q4 | -$0.38 | -$0.27 | -$0.44 | -62.96% | $0.00 | — | $0.00 | — | Get Alert |
11/09/2022 | AM | AVDL | Q3 | -$0.38 | -$0.25 | -$0.33 | -32.00% | $0.00 | — | $0.00 | — | Get Alert |
08/09/2022 | AM | AVDL | Q2 | -$0.33 | -$0.41 | -$1.01 | -146.34% | $0.00 | — | $0.00 | — | Get Alert |
05/09/2022 | AM | AVDL | Q1 | -$0.23 | -$0.43 | -$0.45 | -4.65% | $0.00 | — | $0.00 | — | Get Alert |
03/17/2022 | AM | AVDL | Q4 | -$0.19 | -$0.41 | -$0.38 | 7.32% | $0.00 | — | $0.00 | — | Get Alert |
11/08/2021 | AM | AVDL | Q3 | -$0.20 | -$0.38 | -$0.38 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
08/09/2021 | AM | AVDL | Q2 | -$0.12 | -$0.31 | -$0.33 | -6.45% | $10.09M | — | $0.00 | — | Get Alert |
05/10/2021 | AM | AVDL | Q1 | -$0.02 | -$0.32 | -$0.23 | 28.12% | $12.24M | — | $0.00 | — | Get Alert |
03/09/2021 | AM | AVDL | Q4 | -$0.07 | -$0.27 | -$0.19 | 29.63% | $10.99M | — | $0.00 | — | Get Alert |
11/09/2020 | AM | AVDL | Q3 | -$0.24 | -$0.25 | -$0.20 | 20.00% | $14.23M | — | $0.00 | — | Get Alert |
08/10/2020 | AM | AVDL | Q2 | -$0.23 | -$0.10 | -$0.12 | -20.00% | $17.55M | $7.37M | $10.09M | 36.92% | Get Alert |
05/11/2020 | AM | AVDL | Q1 | -$0.28 | -$0.24 | -$0.02 | 91.67% | $16.44M | $10.15M | $12.24M | 20.62% | Get Alert |
03/12/2020 | AM | AVDL | Q4 | -$0.46 | -$0.24 | -$0.07 | 70.83% | $20.92M | — | $10.99M | — | Get Alert |
11/12/2019 | AM | AVDL | Q3 | -$0.65 | -$0.27 | -$0.24 | 11.11% | $19.83M | $10.25M | $14.23M | 38.82% | Get Alert |
Avadel Pharmaceuticals (AVDL) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on March 4, 2024 for Q4.
The Actual EPS was $-0.32, which missed the estimate of $-0.29.
The Actual Revenue was $19.5M, which beat the estimate of $18.1M.
Browse earnings estimates, EPS, and revenue on all stocks.